Managing refractory Crohn’s disease: challenges and solutions
The goals of treatment for active Crohn’s disease (CD) are to achieve clinical remission and improve quality of life. Conventional therapeutics for moderate-to-severe CD include 5-aminosalicylic acid, corticosteroids, purine analogs, azathioprine, and 6-mercaptopurine. Patients who fail to respond t...
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401331/ |